Overview
Nasreen Noor is a Pediatrics specialist and an Intensive Care Medicine provider in Kansas City, Missouri. Dr. Noor is rated as an Experienced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top area of expertise is Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome).
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Bryce Heese is a Medical Genetics specialist and a Pediatrics provider in Kansas City, Missouri. Dr. Heese is rated as a Distinguished provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). His top areas of expertise are Chromosome 6q Deletion, Phenylketonuria (PKU), Dihydropteridine Reductase Deficiency, and Maternal Hyperphenylalaninemia. Dr. Heese is currently accepting new patients.
Helena Laroche is a primary care provider, practicing in Pediatrics and Internal Medicine in Kansas City, Missouri. Dr. Laroche is rated as an Advanced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Obesity, Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Obesity in Children, and Metabolic Syndrome. Dr. Laroche is currently accepting new patients.
The Childrens Mercy Hospital
Jennifer Gannon is a Pediatrics specialist and a Medical Genetics provider in Kansas City, Missouri. Dr. Gannon is rated as an Advanced provider by MediFind in the treatment of Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome). Her top areas of expertise are Phenylketonuria (PKU), Dihydropteridine Reductase Deficiency, Maternal Hyperphenylalaninemia, and Propionic Acidemia. Dr. Gannon is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)